Weng Kit Wong1, Arlo Upton, Mark G Thomas. 1. Department of Molecular Medicine and Pathology, Faculty of Medical and Health Sciences, The University of Auckland, Auckland, New Zealand.
Abstract
BACKGROUND: Chronic toxoplasmosis has been shown to be strongly associated with a range of neuropsychiatric effects including schizophrenia and suicide. However there have not been any prospective, community-based studies of the neuropsychiatric effects of acute toxoplasmosis in adult immunocompetent patients. METHODS: Adult patients with a positive serum IgM anti-Toxoplasma gondii test result, in the context of an acute illness with lymphadenopathy, were invited to complete a questionnaire seeking information relating to the nature, severity, and duration of symptoms in the months following the diagnosis of acute toxoplasmosis. RESULTS: Laboratory testing identified a total of 187 adults who had a positive serum IgM anti-T. gondii test result between 1 January and 30 November 2011. Consent to contact 108/187 (58%) patients was provided by their family doctor; 37 (34%) of these 108 patients completed and returned the questionnaire. Questionnaires from the 31/108 (29%) patients who reported swollen lymph nodes during their illness were included in the study. Fatigue (90%), headache (74%), difficulty concentrating (52%), and muscle aches (52%) were the most commonly reported symptoms. These symptoms commonly persisted for at least 4 weeks. Twenty-seven of 31 (87%) subjects reported a moderate or severe reduction in their overall physical and mental health during the first 2 months of illness. CONCLUSIONS: Acute toxoplasmosis in immunocompetent adults commonly causes moderately severe neuropsychiatric symptoms that might result from replication of the organism in the central nervous system with consequent effects on brain function. Patients should be advised that such symptoms are common and reassured that they usually resolve completely within a few months.
BACKGROUND:Chronic toxoplasmosis has been shown to be strongly associated with a range of neuropsychiatric effects including schizophrenia and suicide. However there have not been any prospective, community-based studies of the neuropsychiatric effects of acute toxoplasmosis in adult immunocompetent patients. METHODS: Adult patients with a positive serum IgM anti-Toxoplasma gondii test result, in the context of an acute illness with lymphadenopathy, were invited to complete a questionnaire seeking information relating to the nature, severity, and duration of symptoms in the months following the diagnosis of acute toxoplasmosis. RESULTS: Laboratory testing identified a total of 187 adults who had a positive serum IgM anti-T. gondii test result between 1 January and 30 November 2011. Consent to contact 108/187 (58%) patients was provided by their family doctor; 37 (34%) of these 108 patients completed and returned the questionnaire. Questionnaires from the 31/108 (29%) patients who reported swollen lymph nodes during their illness were included in the study. Fatigue (90%), headache (74%), difficulty concentrating (52%), and muscle aches (52%) were the most commonly reported symptoms. These symptoms commonly persisted for at least 4 weeks. Twenty-seven of 31 (87%) subjects reported a moderate or severe reduction in their overall physical and mental health during the first 2 months of illness. CONCLUSIONS:Acute toxoplasmosis in immunocompetent adults commonly causes moderately severe neuropsychiatric symptoms that might result from replication of the organism in the central nervous system with consequent effects on brain function. Patients should be advised that such symptoms are common and reassured that they usually resolve completely within a few months.
Authors: Cosme Alvarado-Esquivel; Luis Francisco Sanchez-Anguiano; Jesus Hernandez-Tinoco; Alma Rosa Perez-Alamos; Yazmin Del Rosario Rico-Almochantaf; Sergio Estrada-Martinez; Raquel Vaquera-Enriquez; Arturo Diaz-Herrera; Agar Ramos-Nevarez; Ada Agustina Sandoval-Carrillo; Jose Manuel Salas-Pacheco; Sandra Margarita Cerrillo-Soto; Elizabeth Irasema Antuna-Salcido; Oliver Liesenfeld; Carlos Alberto Guido-Arreola Journal: J Clin Med Res Date: 2016-08-30
Authors: Cosme Alvarado-Esquivel; Luis Francisco Sánchez-Anguiano; Jesús Hernández-Tinoco; Alma Rosa Pérez-Álamos; Yazmin Del Rosario Rico-Almochantaf; Sergio Estrada-Martínez; Raquel Vaquera-Enriquez; Arturo Díaz-Herrera; Agar Ramos-Nevarez; Ada Agustina Sandoval-Carrillo; José Manuel Salas-Pacheco; Sandra Margarita Cerrillo-Soto; Elizabeth Irasema Antuna-Salcido; Oliver Liesenfeld; Carlos Alberto Guido-Arreola Journal: Eur J Microbiol Immunol (Bp) Date: 2016-11-03
Authors: Cosme Alvarado-Esquivel; Yazmin Del Rosario Rico-Almochantaf; Luis Francisco Sanchez-Anguiano; Gerardo Quinones-Canales; Jesus Hernandez-Tinoco; Jorge Torres-Gonzalez; Maria Felix Gonzalez-Silva; Eda Guadalupe Ramirez-Valles Journal: J Clin Med Res Date: 2017-12-01
Authors: Paul R Torgerson; Brecht Devleesschauwer; Nicolas Praet; Niko Speybroeck; Arve Lee Willingham; Fumiko Kasuga; Mohammad B Rokni; Xiao-Nong Zhou; Eric M Fèvre; Banchob Sripa; Neyla Gargouri; Thomas Fürst; Christine M Budke; Hélène Carabin; Martyn D Kirk; Frederick J Angulo; Arie Havelaar; Nilanthi de Silva Journal: PLoS Med Date: 2015-12-03 Impact factor: 11.069